Publications by authors named "Cai-Yu Lin"

Claim this Profile
A
Anti-EGFR therapy can overcome acquired resistance to the third-generation ALK-tyrosine kinase inhibitor lorlatinib mediated by activation of EGFR.
Chen Hu, Cong-Hua Lu, Jie Zheng, Jun Kang, Dai-Juan Huang, Cai-Yu Lin

Acta Pharmacol Sin· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual winter bloom of dinoflagellates with notable damage to kelp cultivation around Shandong peninsula, China.
Hui-Xia Geng, Fan-Zhou Kong, Jin-Xiu Wang, Qing-Chun Zhang, Fang Li, Yu-Lin Cai

Mar Environ Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer.
Rui Han, Cong-Hua Lu, Chen Hu, Yuan-Yao Dou, Jun Kang, Cai-Yu Lin, Wei-Ling Jiang

Acta Pharmacol Sin· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota-directed intervention with high-amylose maize ameliorates metabolic dysfunction in diet-induced obese mice.
Wei-Chung Chiou, Wei-Han Lai, Yu-Lin Cai, Meng-Lun Du, Hsi-Mei Lai

Food Funct· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synbiotic Intervention with an Adlay-Based Prebiotic and Probiotics Improved Diet-Induced Metabolic Disturbance in Mice by Modulation of the Gut Microbiota.
Wei-Chung Chiou, Bei-Hau Chang, Hsiao-Hsuan Tien, Yu-Lin Cai, Ya-Chi Fan

Nutrients· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling.
Yong-Hong Pan, Cai-Yu Lin, Cong-Hua Lu, Li Li, Yu-Bo Wang

Clin Respir J· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway.
Yong-Hong Pan, Lin Jiao, Cai-Yu Lin, Cong-Hua Lu, Li Li

Biologics· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis